Internal Medicine, Gastroenterology · Montgomery, OH
NPI
1184008948
Since 2015
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
10600 Montgomery Rd Ste 300
Montgomery, OH, 45242
Phone (513) 853-9250
Groups this clinician bills Medicare through
Medicare paid, 2024
$57K
584 services
Medicare patients, 2024
363
Average age 72
Drug cost, 2024
$125K
1,231 prescriptions
Company payments, 2025
$3,102
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Khalil I Aloreidi was code 43239 (upper gi endoscopy), 104 times for 98 patients. In total Khalil I Aloreidi billed 584 services in 42 codes, and Medicare paid $57K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-08-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 43239 Upper GI Endoscopy | Facility | 104 | 98 | $65.22 | $6,783 |
| 45385 Colonoscopy - Lesion Removal | Facility | 100 | 97 | $156.14 | $16K |
| 45380 Lower GI Endoscopy - Other | Facility | 44 | 44 | $69.80 | $3,071 |
| 91010 Test - Miscellaneous | Facility | 27 | 27 | $47.00 | $1,269 |
| 99223 Hospital E&M - Initial | Facility | 25 | 25 | $131.60 | $3,290 |
| 99213 Office E&M - Established | Facility | 25 | 23 | $41.89 | $1,047 |
| 99212 Office E&M - Established | Facility | 24 | 24 | $18.92 | $454 |
| 43235 Upper GI Endoscopy | Facility | 23 | 22 | $69.88 | $1,607 |
| 45390 Lower GI Endoscopy - Other | Facility | 20 | 17 | $228.12 | $4,562 |
| 45378 Lower GI Endoscopy - Other | Facility | 17 | 17 | $129.98 | $2,210 |
| 45385 Colonoscopy - Lesion Removal | Office | 12 | 12 | $190.77 | $2,289 |
| 99203 Office E&M - New | Office | 11 | 11 | $84.15 | $926 |
| 99222 Hospital E&M - Initial | Facility | 11 | 11 | $99.35 | $1,093 |
By year: 2022 $77K for 742 services; 2023 $69K for 692 services; 2024 $57K for 584 services.
Medicare prescription drug claims, 2024
In 2024, the drug Khalil I Aloreidi prescribed most often to Medicare patients was Gavilyte-G (Peg3350/Sod Sulf,bicarb,cl/Kcl), with 364 prescriptions and refills. In total Khalil I Aloreidi wrote 1,231 Medicare prescriptions that cost $125K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 364 | 375 | 347 | $7,191 |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 322 | 322 | 303 | $6,140 |
| Omeprazole Generic | 176 | 378 | 77 | $2,293 |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 104 | 104 | 102 | $2,148 |
| Peg 3350-Electrolyte Sodium Chloride/Nahco3/Kcl/Peg | 58 | 58 | 56 | $1,211 |
| Ondansetron Hcl Generic | 43 | 43 | 41 | $57.04 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 25 | 25 | 25 | $1,673 |
| Esomeprazole Magnesium Generic | 17 | 23 | Under 11 | $379 |
| Pantoprazole Sodium Generic | 16 | 29 | Under 11 | $104 |
| Methotrexate Methotrexate Sodium | 11 | 15 | Under 11 | $436 |
Brand drugs: 374 claims; generic drugs: 857 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Khalil I Aloreidi $3,102 ($3,102 in general payments such as food, travel and fees) from 20 companies. The largest payer was Madrigal Pharmaceuticals with $789.
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals MDGL | 8 | $789 |
| Abbvie Inc. ABBV | 17 | $428 |
| Novo Nordisk Inc NVO | 7 | $331 |
| Janssen Biotech, Inc. JNJ | 4 | $327 |
| Olympus America Inc. | 15 | $221 |
| Evoke Pharma, Inc. EVOK | 6 | $166 |
| Steris Corporation STE | 1 | $137 |
| NeurAxis, Inc. NRXS | 1 | $135 |
| Boston Scientific Corporation BSX | 1 | $130 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 4 | $84.38 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.